UnitedHealth Group Incorporated $UNH Holdings Lifted by Vaughan David Investments LLC IL

Vaughan David Investments LLC IL increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 146,839 shares of the healthcare conglomerate’s stock after buying an additional 1,641 shares during the quarter. Vaughan David Investments LLC IL’s holdings in UnitedHealth Group were worth $50,704,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Brighton Jones LLC lifted its holdings in shares of UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC lifted its holdings in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares in the last quarter. Exchange Traded Concepts LLC grew its holdings in shares of UnitedHealth Group by 48.0% during the second quarter. Exchange Traded Concepts LLC now owns 4,184 shares of the healthcare conglomerate’s stock valued at $1,305,000 after buying an additional 1,357 shares in the last quarter. Lewis Asset Management LLC boosted its position in UnitedHealth Group by 50.6% during the 2nd quarter. Lewis Asset Management LLC now owns 2,060 shares of the healthcare conglomerate’s stock worth $643,000 after acquiring an additional 692 shares during the period. Finally, Rooted Wealth Advisors Inc. lifted its position in shares of UnitedHealth Group by 105.9% in the second quarter. Rooted Wealth Advisors Inc. now owns 1,890 shares of the healthcare conglomerate’s stock worth $575,000 after purchasing an additional 972 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

UNH stock opened at $329.99 on Tuesday. The stock has a market capitalization of $298.92 billion, a PE ratio of 17.29, a price-to-earnings-growth ratio of 2.00 and a beta of 0.42. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $606.36. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.82. The company has a 50 day moving average price of $330.53 and a 200 day moving average price of $322.35.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The firm had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. During the same period in the previous year, the business posted $7.15 EPS. The company’s quarterly revenue was up 12.2% compared to the same quarter last year. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 16th. Investors of record on Monday, December 8th were paid a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, December 8th. This represents a $8.84 annualized dividend and a yield of 2.7%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 46.14%.

Analyst Ratings Changes

A number of analysts recently issued reports on UNH shares. Jefferies Financial Group lifted their price objective on UnitedHealth Group from $317.00 to $409.00 and gave the company a “buy” rating in a research report on Friday, October 17th. Weiss Ratings raised UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, October 24th. Leerink Partners set a $410.00 target price on shares of UnitedHealth Group and gave the company an “outperform” rating in a research note on Wednesday, October 29th. KeyCorp increased their target price on shares of UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a research note on Wednesday, October 8th. Finally, Barclays upped their price target on UnitedHealth Group from $386.00 to $391.00 and gave the company an “overweight” rating in a report on Monday, January 5th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $385.75.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.